zolbetuximab
astellas
[]
adding zolbetuximab to standard frontline chemotherapy can improve outcomes in certain patients with gastric/gej cancer, a phase 3 study suggests. #stcsm presented at #gi23. 
https://t.co/bi63MIVP5D is a resource offering oncology health care professionals practical information about the changing clinical landscape.